
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Impaired memory
Introduction
For patient information, click here
Synonyms and keywords: Amnestic; amnestic disorder; amnestic syndrome; blackout; memory loss; forgetfulness; impaired memory
Overview
Overview
Amnesia can be divided into two broad groups, retrograde amnesia and anterograde amnesia. Retrograde amnesia is the loss of memory prior to the onset of amnesia and anterograde amnesia is the inability to form new memory. Memory can also be divided into two groups depending on the duration, short-term memory and long-term memory. Other types of amnesia are Psychological including repressive amnesia and dissociative fugue, infantile amnesia, neurological amnesia (Alzheimer’s disease, Pick’s disease), post-traumatic Amnesia, drug-Induced Amnesia, transient global amnesia, amnesia due to nutritional deficiency (thiamine, vitamin B12). Richard Semon in 1904 described that experiences cause some changes in the neurons and these changes are referred to as engram and they form memory of the particular experience in those neurons. Reactivation of these neurons occur when patient tries to recall those memories. Amnesia results from damage to different memory centers in the brain, such as the medial temporal lobe and the hippocampus, which are involved in acquiring and restoring memory. Common causes of amnesia include medications, head trauma, depression and aging. Less common cause of amnesia are childhood sexual abuse, traumatic incident, hypoxia, psychological trauma, thiamine deficiency, alcohol abuse, Alzheimer’s disease, Pick’s disease, Parkinson’s disease, benzodiazepines, hypoglycemia, stroke, electroconvulsive therapy. The underlying etiology of memory loss must be differentiated on the basis of duration of memory loss, presence of anterograde amnesia or retrograde amnesia, associated features, and cognitive impairment. Memory impairment tends to increase with age. Forty percent of the population over age sixty have some degree of memory loss. Amnesia and mild cognitive impairment is more prevalent in middle-aged to older Non-Hispanic Black and older Latino as compared to non-Hispanic Whites. Aging, depression, chronic stress, head trauma, chronic sleep deprivation and medications are risk factors βfor amnesia. Amnesia may progress slowly or suddenly, and maybe transient or permanent. The natural history and prognosis depends upon the underlying etiology. Patients with memory loss could suffer from depression and grief long term. Quality of life and activities of daily living are difficult to maintain which causes decreased socialization and a decline in cognitive functions in the elderly.Amnesia is largely a clinical diagnosis, a detailed history of memory impairment and associated symptoms should be obtained. Focal examination including vital signs, altered mental status, mini mental status exam (MMSE), Glasgow Coma Scale, nystagmus, papilledema, gait, instruments of daily activities should be assessed. Head CT scan and MRI may be helpful in identifying structural and functional abnormalities including bleeding, stroke, tumor, atrophy or any changes suggestive of amnesia. Positron emission tomography PET may show hypometabolism in areas of brain associated with memory in patients with history of amnesia but with no visible structural or functional brain damage on CT scan or MRI. Other diagnostic studies helpful in the diagnosis of the cause amnesia are EEG for epilepsy, CSF fluid analysis for encephalitis.Treatment can be offered in cases of reversible conditions. If not, provision of supportive care can help to improve a patient’s condition. Etiology specific treatment plan should be followed to improve memory and delay progression. Surgical intervention is not recommended for the management of memory loss. Measures for the primary prevention of amnesia include preventing brain trauma, managing stress, avoid alcohol abuse, manage stroke risk factors, good sleep habits, social integration, optimum nutrition and exercise routine. Effective measures for the secondary prevention of memory loss include, sustainable daily routine, healthy eating habits, social integration, exercise routine, reduce and manage stress, adequate sleep, reading and playing strategic games like puzzles and word games.
Historical Perspective
Richard Semon in 1904 described that experiences cause some changes in the neurons and these changes are referred to as engram and they form memory of the particular experience in those neurons. Reactivation of these neurons occur when patient tries to recall those memories. Theodule-Armand Ribot, a French psychologist determined that memory loss affects recent memories first. Memories are lost in reverse order of their development.
Classification
Amnesia can be divided into two broad groups, retrograde amnesia and anterograde amnesia. Retrograde amnesia is the loss of memory prior to the onset of amnesia and anterograde amnesia is the inability to form new memory. Other types of amnesia are Psychological including repressive amnesia and dissociative fugue, infantile amnesia, neurological amnesia (Alzheimer’s disease, Pick’s disease), post-traumatic Amnesia, drug-Induced Amnesia, transient global amnesia. Memory can also be divided into two groups depending on the duration, short-term memory and long-term memory.
Pathophysiology
Amnesia results from damage to different memory centers in the brain, such as the medial temporal lobe and the hippocampus, which are involved in acquiring and restoring memory.
Causes
Common causes of amnesia include medications, head trauma, depression and aging. Less common cause of amnesia are childhood sexual abuse, traumatic incident, hypoxia, psychological trauma, thiamine deficiency, alcohol abuse, Alzheimer’s disease, Pick’s disease, Parkinson’s disease, benzodiazepines, hypoglycemia, stroke, electroconvulsive therapy.
Differentiating Amnesia from other Diseases
The underlying etiology of memory loss must be differentiated on the basis of duration of memory loss, presence of anterograde amnesia or retrograde amnesia, associated features, and cognitive impairment.
Epidemiology and Demographics
Memory impairment tends to increase with age. Forty percent of the population over age sixty have some degree of memory loss. Amnesia and mild cognitive impairment is more prevalent in middle-aged to older Non-Hispanic Black and older Latino as compared to non-Hispanic Whites.
Risk Factors
Aging, depression, chronic stress, head trauma, chronic sleep deprivation and medications are risk factors βfor amnesia.
Natural History, Complications and Prognosis
Amnesia may progress slowly or suddenly, and maybe transient or permanent. The natural history and prognosis depends upon the underlying etiology. Patients with memory loss could suffer from depression and grief long term. Quality of life and activities of daily living are difficult to maintain which causes decreased socialization and a decline in cognitive functions in the elderly.
Diagnosis
Diagnostic Study of Choice
There is no diagnostic study of choice to diagnose amnesia. The best approach is to obtain a detailed history followed by a focused physical examination.
History and Symptoms
It is critical to perform a formal and exhaustive assessment of the patient to look for any indications of memory disorders and to hear any subjective complaints. With this information, preventative measures and care can be specifically addressed to the patient’s needs. A detailed history of memory loss and associated symptoms is crucial for understanding the etiology of amnesia.
Physical Examination
Patients with amnesia may have variable general appearance depending on the underlying cause of memory loss. Amnesia is largely a clinical diagnosis. Focal examination including vital signs, altered mental status, mini mental status exam (MMSE), Glasgow Coma Scale, nystagmus, papilledema, gait, instruments of daily activities should be assessed.
Laboratory Findings
There is no laboratory test to diagnose memory loss. however, it is important to obtain toxicology screening, alcohol, glucose, electrolytes level.
Electrocardiogram
There are no ECG findings associated with amnesia.
X-ray
There are no x-ray findings associated with amnesia.
Echocardiography and Ultrasound
There are no echocardiography/ultrasound findings associated with amnesia. Although a case of transient global amnesia has been reported in a patient undergoing a transesophageal echocardiogram (TEE).
CT
Head CT scan may be helpful in the diagnosis of the cause of amnesia. Structural and functional abnormalities are identified to detect any bleeding, stroke, tumor, atrophy or any changes suggestive of amnesia.
MRI
Head MRI may be helpful in the diagnosis of the cause of amnesia in some cases including, Alzheimer’s disease, or brain trauma. In majority of the cases of amnesia the brain appears normal on MRI.
Other Imaging Findings
Positron emission tomography PET may show hypometabolism in areas of brain associated with memory in patients with history of amnesia but with no visible structural or functional brain damage on CT scan or MRI.
Other Diagnostic study
Other diagnostic studies helpful in the diagnosis of the cause amnesia are EEG for epilepsy, CSF fluid analysis for encephalitis.
Treatment
Medical Therapy
Treatment can be offered in cases of reversible conditions. If not, provision of supportive care can help to improve a patient’s condition. Etiology specific treatment plan should be followed to improve memory and delay progression. When memory loss is a symptom of a more severe disease, it may be reversed as soon as the underlying condition is identified and cured. Memory loss due to aging cannot be cured, but the symptoms may be improved by preventative measures.
Surgery
Surgical intervention is not recommended for the management of memory loss.
Primary Prevention
Measures for the primary prevention of amnesia include preventing brain trauma, managing stress, avoid alcohol abuse, manage stroke risk factors, good sleep habits, social integration, optimum nutrition and exercise routine.
Secondary Prevention
Effective measures for the secondary prevention of memory loss include, sustainable daily routine, healthy eating habits, social integration, exercise routine, reduce and manage stress, adequate sleep, reading and playing strategic games like puzzles and word games.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Historical Perspective
Overview
Richard Semon in 1904 described that experiences cause some changes in the neurons and these changes are referred to as engram and they form memory of the particular experience in those neurons. Reactivation of these neurons occur when patient tries to recall those memories. Theodule-Armand Ribot, a French psychologist determined that memory loss affects recent memories first. Memories are lost in reverse order of their development.
Historical Perspective
- Richard Semon in 1904 described that experiences cause some changes in the neurons and these changes are referred to as engram and they form memory of the particular experience in those neurons. Reactivation of these neurons occur when patient tries to recall those memories.[1]
- Theodule-Armand Ribot, a French psychologist determined that memory loss affects recent memories first. Memories are lost in reverse order of their development.[2]
- In 1763, Sauvages recognized amnesia as a medical disorder.[3]
- In early 19th century clinical description of amnesia was identified.[3]
- Caroline Miles and Henri & Henri first described infantile amnesia in 1893 and 1895,respectively. It was further explained by Sigmund Freud in 1953.[4]
- Alzheimer’s disease was first described in 1906 by Alois Alzheimer, a psychiatrist and a pathologist of German origin.[5]
- Korsakoff syndrome was discovered in late 19th century by a neuropsychiatrist of russian origin named, Sergei Korsakoff.[6]
References
- β Semon R. (1904). Die mneme [The mneme]. Edited by W. Engelmann. Leipzig
- β Clark RE (2018). “A History and Overview of the Behavioral Neuroscience of Learning and Memory”. Curr Top Behav Neurosci. 37: 1β11. doi:10.1007/7854_2017_482. PMIDΒ 29589321.
- β 3.0 3.1 Langer KG (2019). “Early History of Amnesia”. Front Neurol Neurosci. 44: 64β74. doi:10.1159/000494953. PMIDΒ 31220849.
- β Alberini CM, Travaglia A (2017). “Infantile Amnesia: A Critical Period of Learning to Learn and Remember”. J Neurosci. 37 (24): 5783β5795. doi:10.1523/JNEUROSCI.0324-17.2017. PMCΒ 5473198. PMIDΒ 28615475.
- β Berchtold NC, Cotman CW (1998). “Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s”. Neurobiol Aging. 19 (3): 173β89. doi:10.1016/s0197-4580(98)00052-9. PMIDΒ 9661992.
- β Vein A (2009). “Sergey Sergeevich Korsakov (1854-1900)”. J Neurol. 256 (10): 1782β3. doi:10.1007/s00415-009-5289-x. PMCΒ 2758215. PMIDΒ 19690905.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Classification
Overview
Amnesia can be divided into two broad groups, retrograde amnesia and anterograde amnesia. Retrograde amnesia is the loss of memory prior to the onset of amnesia and anterograde amnesia is the inability to form new memory. Other types of amnesia are Psychological including repressive amnesia and dissociative fugue, infantile amnesia, neurological amnesia (Alzheimer’s disease, Pick’s disease), post-traumatic Amnesia, drug-Induced Amnesia, transient global amnesia.Memory can also be divided into two groups depending on the duration, short-term memory and long-term memory.
Classification
- Amnesia can be divided into two broad groups:
- Anterograde amnesia: The inability to form new memory. Past memory is intact.
- Retrograde amnesia: The loss of memory prior to the onset of amnesia. Patient can form new memories.
- Memory can also be divided into groups depending on the duration:
| Types of Amnesia | Main Features |
|---|---|
| Dissociative Amnesia | Temporary, episodic retrograde memory loss without structural brain damage. Cause is psychological in origin. Dissociative Amnesia is also referred to as psychological amnesia. It has variable presentation:
|
| Transient global amnesia | Sudden episodic loss of anterograde and partial retrograde memory. Usually last less than twenty four hours.[4] |
| Post-traumatic Amnesia | Amnesia that follows head trauma could be temporary or permanent. The span of memory loss is uncertain it could present with retrograde, anterograde or combined. Extent of injury and duration of loss of consciousness are important prognostic factors in determining the severity of amnesia. [5] |
| Infantile Amnesia | Also known as childhood amnesia. Early childhood memory is lost, usually up to the age of fours year. Influenced by cultural norms and sexual repression.[6] |
| Drug-Induced Amnesia | Benzodiazepine are the most common group of drugs that can cause drug-induced amnesia, especially if used with alcohol. Memory loss could be long term or short term.[7] Amnesia is anterograde from the time the drug was introduced and patient has impairment in forming new memories. It is reversible upon discontinuation of the drug. |
| Neurological Amnesia | Alzheimer’s Disease, Pick’s Disease, Parkinson’s Disease |
| Amnesia in Korsakoffβs Syndrome | Caused by thiamine deficiency due to prolonged alcohol use or severe malnutrition. Anterograde amnesia, retrograde amnesia, and confabulation.[8] |
| Selective Amnesia | Certain memory is lost. Patient may forget about certain relationships, talents, events, or traumatic incidents. |
| Epileptic Amnesia | Observed in patients with temporal lobe epilepsy.[9] Anterograde amnesia with short-term memory loss. |
| Lacunar amnesia | Memory of a particular event is lost. Lacuna mean ‘a gap’, which refers to leaving ‘a gap’ in memory.[10] |
References
- β Bisaz R, Travaglia A, Alberini CM (2014). “The neurobiological bases of memory formation: from physiological conditions to psychopathology”. Psychopathology. 47 (6): 347β56. doi:10.1159/000363702. PMCΒ 4246028. PMIDΒ 25301080.
- β Bourget D, Whitehurst L (2007). “Amnesia and crime”. J Am Acad Psychiatry Law. 35 (4): 469β80. PMIDΒ 18086739.
- β American Psychiatric Association (2013). Diagnostic and statistical manual of mental disordersΒ : DSM-5
- β Profice P, Rizzello V, PennestrΓ¬ F, Pilato F, Della Marca G, Sestito A; et al. (2008). “Transient global amnesia during transoesophageal echocardiogram”. Neurol Sci. 29 (6): 477β9. doi:10.1007/s10072-008-1034-y. PMIDΒ 19031042.
- β Leclerc S, Lassonde M, Delaney JS, Lacroix VJ, Johnston KM (2001). “Recommendations for grading of concussion in athletes”. Sports Med. 31 (8): 629β36. doi:10.2165/00007256-200131080-00007. PMIDΒ 11475324.
- β Wang Q (2003). “Infantile amnesia reconsidered: a cross-cultural analysis”. Memory. 11 (1): 65β80. doi:10.1080/741938173. PMIDΒ 12653489.
- β Sadock, Benjamin J., and Virginia A. Sadock. Kaplan & Sadock’s concise textbook of clinical psychiatry. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2008. Print
- β Kolb, Bryan, and Ian Q. Whishaw. Fundamentals of human neuropsychology. New York, NY: Worth Publishers, 2003. Print.
- β Kopelman MD (2002). “Disorders of memory”. Brain. 125 (Pt 10): 2152β90. doi:10.1093/brain/awf229. PMIDΒ 12244076.
- β Benezech M, Leyssenne JP (1978). “[Lacunar amnesia and criminal behaviourΒ : realities and medico-legal consequences]”. Ann Med Psychol (Paris). 136 (6β8): 918β29. PMIDΒ 747264.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Pathophysiology
Overview
Memory is the stored information in the hippocampal region of the brain. depending on the duration, memory is divided into short term and long term.
Pathophysiology
Physiology
Memory is the stored information in the hippocampal region of the brain. According to Richard Semon (1904), experiences cause some structural and functional changes in the neurons and these changes are referred to as engram and they form memory of that experience. Reactivation of these neurons occur when patient tries to recall those memories.[1] Memory is divided into groups depending on the duration:
- Sensory memory: Information from around us is stored as sensory memory.[2]
- Short-term memory are for short period of time and use existing neuronal network.
- Long-term memory are long lasting and are formed by structural/functional changes in neuronal network.[3]
Pathogenesis
| Types of Amnesia | Pathogenesis |
|---|---|
| Dissociative Amnesia | Psychological origin. |
| Transient global amnesia | Precipitated by brain ischemia, migraine, epileptic seizure, venous congestion, psychological trauma.[4] |
| Post-traumatic Amnesia | Amnesia that follows head trauma could be temporary or permanent.[5] |
| Infantile Amnesia | Influenced by cultural norms and sexual repression.[6] |
| Drug-Induced Amnesia | Benzodiazepine are the most common group of drugs that can cause drug-induced amnesia, especially if used with alcohol.[7] |
| Neurologically Derived Amnesia | Brain regions involved are the hippocampus and the medial temporal lobes.[8] |
| Amnesia in Korsakoffβs Syndrome | Caused by thiamine deficiency due to prolonged alcohol use or severe malnutrition. Deficiency of thiamine damages medial thalamus, mammillary bodies and causes cerebral atrophy due to lack of pyruvate decarboxylation.[9] |
| Epileptic Amnesia | Rare, episodic amnesia seen in patients with temporal lobe epilepsy.[10] |
| Lacunar amnesia | Occurs due to brain damage. These patients have a gap in memory.[11] |
Genetics
- Alzheimer’s disease:[12]
- Late-onset: Apolipoprotein E (APOE) gene on chromosome 19. This gene has variable risk of developing Alzheimer’s disease depending on the allele. APOE Ξ΅4 increases the risk, APOE Ξ΅3 neither increases nor decreases and APOE Ξ΅2 allele provides some protection against the disease.
- Early-onset: Amyloid precursor protein (APP) on chromosome 21, presenilin 1 (PSEN1) on chromosome 14 and presenilin 2 (PSEN2) on chromosome 1 are associated with early-onset Alzheimer’s disease.
- Deficiency of RbAp48 protein encoded by RBBP4 gene have been co-related to memory loss.[13]
Gross Pathology
On gross pathology, generalized cortical atrophy, more pronounced in hippocampus and medial temporal lobe is seen in patients with Alzheimer’s disease.[14]
Microscopic Pathology
- Korsakoff’s syndrome:[15]
- Gliosis and microhemorrhages found in periaqueductal and paraventricular region.,
- Mamillary bodies atrophy and
- Atrophy seen in thalamus
- Microscopic features seen in Alzheimer’s disease are, amyloid plaques, intracellular neurofibrillary tangles, tau-positive neuropil threads, dystrophic neurites, activated microglia, reactive astrocytes, eosinophilic Hirano bodies, granulovacuolar degeneration and cerebral amyloid angiopathy.[14]
References
- β Semon R. (1904). Die mneme [The mneme]. Edited by W. Engelmann. Leipzig
- β Camina E, GΓΌell F (2017). “The Neuroanatomical, Neurophysiological and Psychological Basis of Memory: Current Models and Their Origins”. Front Pharmacol. 8: 438. doi:10.3389/fphar.2017.00438. PMCΒ 5491610. PMIDΒ 28713278.
- β Bisaz R, Travaglia A, Alberini CM (2014). “The neurobiological bases of memory formation: from physiological conditions to psychopathology”. Psychopathology. 47 (6): 347β56. doi:10.1159/000363702. PMCΒ 4246028. PMIDΒ 25301080.
- β Profice P, Rizzello V, PennestrΓ¬ F, Pilato F, Della Marca G, Sestito A; et al. (2008). “Transient global amnesia during transoesophageal echocardiogram”. Neurol Sci. 29 (6): 477β9. doi:10.1007/s10072-008-1034-y. PMIDΒ 19031042.
- β Leclerc S, Lassonde M, Delaney JS, Lacroix VJ, Johnston KM (2001). “Recommendations for grading of concussion in athletes”. Sports Med. 31 (8): 629β36. doi:10.2165/00007256-200131080-00007. PMIDΒ 11475324.
- β Wang Q (2003). “Infantile amnesia reconsidered: a cross-cultural analysis”. Memory. 11 (1): 65β80. doi:10.1080/741938173. PMIDΒ 12653489.
- β Sadock, Benjamin J., and Virginia A. Sadock. Kaplan & Sadock’s concise textbook of clinical psychiatry. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2008. Print
- β Allen RJ (2018). “Classic and recent advances in understanding amnesia”. F1000Res. 7: 331. doi:10.12688/f1000research.13737.1. PMCΒ 5861508. PMIDΒ 29623196.
- β Kolb, Bryan, and Ian Q. Whishaw. Fundamentals of human neuropsychology. New York, NY: Worth Publishers, 2003. Print.
- β Walsh RD, Wharen RE, Tatum WO (2011). “Complex transient epileptic amnesia”. Epilepsy Behav. 20 (2): 410β3. doi:10.1016/j.yebeh.2010.12.026. PMIDΒ 21262589.
- β Benezech M, Leyssenne JP (1978). “[Lacunar amnesia and criminal behaviourΒ : realities and medico-legal consequences]”. Ann Med Psychol (Paris). 136 (6β8): 918β29. PMIDΒ 747264.
- β Bekris LM, Yu CE, Bird TD, Tsuang DW (2010). “Genetics of Alzheimer disease”. J Geriatr Psychiatry Neurol. 23 (4): 213β27. doi:10.1177/0891988710383571. PMCΒ 3044597. PMIDΒ 21045163.
- β Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O; et al. (2013). “Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48”. Sci Transl Med. 5 (200): 200ra115. doi:10.1126/scitranslmed.3006373. PMCΒ 4940031. PMIDΒ 23986399.
- β 14.0 14.1 DeTure MA, Dickson DW (2019). “The neuropathological diagnosis of Alzheimer’s disease”. Mol Neurodegener. 14 (1): 32. doi:10.1186/s13024-019-0333-5. PMCΒ 6679484 Check
|pmc=value (help). PMIDΒ 31375134. - β Sullivan EV, Pfefferbaum A (2009). “Neuroimaging of the Wernicke-Korsakoff syndrome”. Alcohol Alcohol. 44 (2): 155β65. doi:10.1093/alcalc/agn103. PMCΒ 2724861. PMIDΒ 19066199.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Causes
Overview
Common causes of amnesia include medications, head trauma, depression and aging. Less common cause of amnesia are childhood sexual abuse, traumatic incident, psychological trauma, hypoxia, thiamine deficiency, alcohol abuse, Alzheimer’s disease, Pick’s disease, Parkinson’s disease, benzodiazepines, hypoglycemia, stroke, electroconvulsive therapy.
Causes
Common Causes
- Common causes of amnesia include medications, head trauma, depression and aging.[1]
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Amnesia | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | ||||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Neurological | Β | Trauma | Β | Psychological | Β | Drug Induced | Β | Nutrition deficiency | Β | Β | Β | Β | Β | Β | ||||||||||||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||
Β | Β | Β | Β | Β | β’Alzheimer’s Disease β’Parkinson’s Disease β’Dementia with Lewy bodies β’Frontotemporal lobar degeneration β’Stroke | Β | β’Vascular dementia β’Radiation[2] | Β | β’Depression[1] β’Anxiety β’Childhood sexual abuse | Β | β’Marijuana abuse β’Benzodiazepine[3] β’Chemotherapy[2] β’Electroconvulsive therapy[4] | Β | β’Thiamine deficiency β’Vitamin B12 deficiency β’Hypoxia[1] β’Hypoglycemia[1] | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||||||||||||||||
References
- β 1.0 1.1 1.2 1.3 Erickson KR (1990). “Amnestic disorders. Pathophysiology and patterns of memory dysfunction”. West J Med. 152 (2): 159β66. PMCΒ 1002292. PMIDΒ 2154898.
- β 2.0 2.1 Cascella M, Di Napoli R, Carbone D, Cuomo GF, Bimonte S, Muzio MR (2018). “Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives”. Recenti Prog Med. 109 (11): 523β530. doi:10.1701/3031.30289. PMIDΒ 30565571.
- β Sadock, Benjamin J., and Virginia A. Sadock. Kaplan & Sadock’s concise textbook of clinical psychiatry. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2008. Print
- β Benbow, SM (2004) “Adverse effects of ECT”. In AIF Scott (ed.) The ECT Handbook, second edition. London: The Royal College of Psychiatrists, pp. 170β174.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Differentiating Amnesia from other Diseases
Overview
The underlying etiology of memory loss must be differentiated on the basis of duration of memory loss, presence of anterograde amnesia or retrograde amnesia, associated features, and cognitive impairment.
Amnesia Differential Diagnosis
| Diseases | Differentiating Features | ||
|---|---|---|---|
| Duration of Amnesia | Associated Features | Cognitive Impairment | |
| Post-traumatic amnesia[1] | Varies | Head Trauma | Variable, depends on the extent of brain injury[2] |
| Dissociative Amnesia[3][4] | Variable. Could last minutes, hours, or rarely even months or years | Usually follows an incident that caused a lot of stress and trauma | No cognitive impairment |
| Transient global amnesia[5] | Less than 24hrs | Brain ischemia, migraine, seizure, venous congestion, psychological trauma. | No cognitive impairment |
| Drug-Induced Amnesia[6] | Once drug is stopped, memory gradually regained | Benzodiazepines | No cognitive impairment |
| Neurological Amnesia | Does not resolve, patient experiences progressive memory loss. | Alzheimer’s disease, Pick’s disease, Parkinson’s disease | Progressive cognitive impairment |
| Transient epileptic amnesia[7] | Episodic transient amnesia | History of temporal lobe epilepsy | No cognitive impairment |
| Age-Related Amnesia[8] | Slow and progressive memory loss | Diagnosis of exclusion | No cognitive impairment |
References
- β Leclerc S, Lassonde M, Delaney JS, Lacroix VJ, Johnston KM (2001). “Recommendations for grading of concussion in athletes”. Sports Med. 31 (8): 629β36. doi:10.2165/00007256-200131080-00007. PMIDΒ 11475324.
- β Wortzel HS, Arciniegas DB (2012). “Treatment of post-traumatic cognitive impairments”. Curr Treat Options Neurol. 14 (5): 493β508. doi:10.1007/s11940-012-0193-6. PMCΒ 3437653. PMIDΒ 22865461.
- β Bourget D, Whitehurst L (2007). “Amnesia and crime”. J Am Acad Psychiatry Law. 35 (4): 469β80. PMIDΒ 18086739.
- β American Psychiatric Association (2013). Diagnostic and statistical manual of mental disordersΒ : DSM-5
- β Profice P, Rizzello V, PennestrΓ¬ F, Pilato F, Della Marca G, Sestito A; et al. (2008). “Transient global amnesia during transoesophageal echocardiogram”. Neurol Sci. 29 (6): 477β9. doi:10.1007/s10072-008-1034-y. PMIDΒ 19031042.
- β Amnesia is anterograde from the time the drug was introduced and patient has impairment in forming new memories. It is reversible upon discontinuation of the drug.
- β Zeman AZ, Boniface SJ, Hodges JR (1998). “Transient epileptic amnesia: a description of the clinical and neuropsychological features in 10 cases and a review of the literature”. J Neurol Neurosurg Psychiatry. 64 (4): 435β43. doi:10.1136/jnnp.64.4.435. PMCΒ 2170058. PMIDΒ 9576532.
- β Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M; et al. (2007). “Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline”. Eur J Neurol. 14 (1): e1β26. doi:10.1111/j.1468-1331.2006.01605.x. PMIDΒ 17222085.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Epidemiology and Demographics
Overview
Memory impairment tends to increase with age. Forty percent of the population over age sixty have some degree of memory loss. Amnesia and mild cognitive impairment is more prevalent in middle-aged to older Non-Hispanic Black and older Latino as compared to non-Hispanic Whites.
Epidemiology and Demographics
Prevalence
- The prevalence of dissociative amnesia is 1,000 to 2,600 per 100,000 (1.0% to 2.6%) of the overall population.[1]
- Prevalence of Alzheimer’s disease is 20% over the age of 85.[2]
- The prevalence of dissociative fugue is approximately 0.2%. This might be underestimated as dissociative fugue is under diagnosed.[3]
- Worldwide prevalence of Korsakoff Syndrome is 0-2% and 1-2% in the United States. Prevalence is higher in elderly living by themselves, psychiatric inpatients and the homeless.[4]
Incidence
- Worldwide, the incidence of transient global amnesia is approximately 2.9β 10 per 100,000 cases per year. [5]
- Incidence of dissociative disorder is higher in substance abuse cases.[6]
Gender
- Higher prevalence of Alzheimer’s disease is seen in women than men.[7]
- Males are more affected by Korsakoff Syndrome than females.
Race
- Memory loss and mild cognitive impairment is more prevalent in middle-aged to older Non-Hispanic Black and older Latino as compared to non-Hispanic Whites.[8]
Age
- Memory impairment tends to increase with age. Forty percent of the population over age sixty have some degree of memory loss.[9]
References
- β Diagnostic and statistical manual of mental disordersΒ : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBNΒ 0890425558.
- β Erickson KR (1990). “Amnestic disorders. Pathophysiology and patterns of memory dysfunction”. West J Med. 152 (2): 159β66. PMCΒ 1002292. PMIDΒ 2154898.
- β Mamarde A, Navkhare P, Singam A, Kanoje A (2013). “Recurrent dissociative fugue”. Indian J Psychol Med. 35 (4): 400β1. doi:10.4103/0253-7176.122239. PMCΒ 3868095. PMIDΒ 24379504.
- β Arts NJ, Walvoort SJ, Kessels RP (2017). “Korsakoff’s syndrome: a critical review”. Neuropsychiatr Dis Treat. 13: 2875β2890. doi:10.2147/NDT.S130078. PMCΒ 5708199. PMIDΒ 29225466.
- β Quinette P, Guillery-Girard B , Dayan J , et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 2006;129 (Part 7) :1640β58.
- β Vedat Sar, “Epidemiology of Dissociative Disorders: An Overview”, Epidemiology Research International, vol. 2011, Article ID 404538, 8 pages, 2011. https://doi.org/10.1155/2011/404538
- β Schmidt R, Kienbacher E, Benke T, Dal-Bianco P, Delazer M, Ladurner G; et al. (2008). “[Sex differences in Alzheimer’s disease]”. Neuropsychiatr. 22 (1): 1β15. PMIDΒ 18381051.
- β Casillas A, Liang LJ, Vassar S, Brown A (2019). “Trends in Memory Problems and Race/Ethnicity in the National Health and Examination Survey, 1999-2014”. Ethn Dis. 29 (3): 525β534. doi:10.18865/ed.29.3.525. PMCΒ 6645717 Check
|pmc=value (help). PMIDΒ 31367174. - β Pokorski RJ (2002). “Differentiating age-related memory loss from early dementia”. J Insur Med. 34 (2): 100β13. PMIDΒ 15305786.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Risk Factors
Overview
Aging, depression, chronic stress, head trauma, chronic sleep deprivation and medications are risk factors for amnesia.
Risk Factors
- A psychologically traumatic incident in the past can increase chances of developing dissociative amnesia (psychogenic amnesia).[1]
- Head trauma increases the risk of post traumatic amnesia.[2]
- Sexual repression in childhood and cultural norms can cause infantile/childhood amnesia in adults.[3]
- Prolonged trauma and childhood sexual abuse can increase risk of dissociative fugue.
- Sleep deprivation[4]
- Head trauma, depression, hypertension, Down syndrome and family history can increase the risk of developing Alzheimer’s disease.[5]
- Risk factors for Korsakoff Syndrome include prolonged alcohol use, chemotherapy, dialysis, extreme dieting, severe malnutrition, genetic factors.[6]
- Chronic stress[7]
- Decreased socialization[8]
References
- β Khalili M, Wong RJ (2018). “Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net”. Dig Dis Sci. 63 (12): 3250β3252. doi:10.1007/s10620-018-5316-9. PMCΒ 6436636. PMIDΒ 30311153.
- β Leclerc S, Lassonde M, Delaney JS, Lacroix VJ, Johnston KM (2001). “Recommendations for grading of concussion in athletes”. Sports Med. 31 (8): 629β36. doi:10.2165/00007256-200131080-00007. PMIDΒ 11475324.
- β Wang Q (2003). “Infantile amnesia reconsidered: a cross-cultural analysis”. Memory. 11 (1): 65β80. doi:10.1080/741938173. PMIDΒ 12653489.
- β Alhola P, Polo-Kantola P (2007). “Sleep deprivation: Impact on cognitive performance”. Neuropsychiatr Dis Treat. 3 (5): 553β67. PMCΒ 2656292. PMIDΒ 19300585.
- β Burns A, Iliffe S (2009). “Alzheimer’s disease”. BMJ. 338: b158. doi:10.1136/bmj.b158. PMIDΒ 19196745.
- β Rosenblum, Laurie B. (March 2011). “Korsakoff’s Syndrome”. NYU Langone Medical Center.
- β Peavy GM, Salmon DP, Jacobson MW, Hervey A, Gamst AC, Wolfson T; et al. (2009). “Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults”. Am J Psychiatry. 166 (12): 1384β91. doi:10.1176/appi.ajp.2009.09040461. PMCΒ 2864084. PMIDΒ 19755573.
- β Ertel KA, Glymour MM, Berkman LF (2008). “Effects of social integration on preserving memory function in a nationally representative US elderly population”. Am J Public Health. 98 (7): 1215β20. doi:10.2105/AJPH.2007.113654. PMCΒ 2424091. PMIDΒ 18511736.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Natural History, Complications and Prognosis
Overview
Amnesia may progress slowly or suddenly, and maybe transient or permanent. The natural history and prognosis depends upon the underlying etiology. Patients with memory loss could suffer from depression and grief long term. Quality of life and activities of daily living are difficult to maintain which causes decreased socialization and a decline in cognitive functions in the elderly.
Natural History
- Amnesia may progress slowly or suddenly, and maybe transient or permanent. The natural history and prognosis depends upon the underlying cause.
- Without treatment Korsakoff’s syndrome can cause mental disability with permanent memory loss, apathy, confabulation.[1]
Complications
- Patients with memory loss could suffer from depression and grief long term.[2]
- Quality of life and activities of daily living are difficult to maintain which causes decreased socialization and a decline in cognitive functions in the elderly.[3]
- Repeated episodes of transient global amnesia can result in long lasting loss of memory.[4]
Prognosis
- In patients with post traumatic amnesia, the extent of injury and duration of loss of consciousness are important prognostic factors in determining the severity of amnesia. [5]
- Dissociative fugue could last from days to months and once recovery occurs it is rapid and complete. Some refractory cases have been observed but usually it is just one episode.[2]
- If Korsakoff’s syndrome is detected early and treatment optimally it can be reversed to some extent and can prevent further brain and nerve damage.[1]
References
- β 1.0 1.1 Arts NJ, Walvoort SJ, Kessels RP (2017) Korsakoff’s syndrome: a critical review. Neuropsychiatr Dis Treat 13 ():2875-2890. DOI:10.2147/NDT.S130078 PMID: 29225466
- β 2.0 2.1 Mamarde A, Navkhare P, Singam A, Kanoje A (2013). “Recurrent dissociative fugue”. Indian J Psychol Med. 35 (4): 400β1. doi:10.4103/0253-7176.122239. PMCΒ 3868095. PMIDΒ 24379504.
- β Ertel KA, Glymour MM, Berkman LF (2008). “Effects of social integration on preserving memory function in a nationally representative US elderly population”. Am J Public Health. 98 (7): 1215β20. doi:10.2105/AJPH.2007.113654. PMCΒ 2424091. PMIDΒ 18511736.
- β Profice P, Rizzello V, PennestrΓ¬ F, Pilato F, Della Marca G, Sestito A; et al. (2008). “Transient global amnesia during transoesophageal echocardiogram”. Neurol Sci. 29 (6): 477β9. doi:10.1007/s10072-008-1034-y. PMIDΒ 19031042.
- β Leclerc S, Lassonde M, Delaney JS, Lacroix VJ, Johnston KM (2001). “Recommendations for grading of concussion in athletes”. Sports Med. 31 (8): 629β36. doi:10.2165/00007256-200131080-00007. PMIDΒ 11475324.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Diagnosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
